A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1801 in Healthy Subjects
Clinical trial NCT03826641 · COMPLETED
Trial details
- NCT number
- NCT03826641
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-01
- Primary completion
- 2019-03-25
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.